Trial
NCT05582707
Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Maryland, Baltimore
Collaborators
Nico Corporation
Condition
Intracerebral Haemorrhage, Intraventricular
Intervention
Pioglitazone 15mg
Why stopped
Loss of Financial Sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-28